SMAD2 and transient ischemic attack: In conclusion, our findings indicated that miRNA‐21a‐5p targeted RBMS3 and then modulated the downstream TGFBR1/SMAD2/3 pathway to affect the angiogenic activities of mBMECs and regulate angiogenesis after TIA.